In re: Taxotere Prod Liability

CourtCourt of Appeals for the Fifth Circuit
DecidedJuly 16, 2020
Docket19-30640
StatusPublished

This text of In re: Taxotere Prod Liability (In re: Taxotere Prod Liability) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re: Taxotere Prod Liability, (5th Cir. 2020).

Opinion

Case: 19-30640 Document: 00515492836 Page: 1 Date Filed: 07/16/2020

IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 19-30640

IN RE: TAXOTERE (DOCETAXEL) PRODUCTS LIABILITY LITIGATION

-------------------------------------------------------- United States Court of Appeals Fifth Circuit

FILED DOROTHY KUYKENDALL, July 16, 2020

Plaintiff - Appellant Lyle W. Cayce Clerk v.

ACCORD HEALTHCARE, INCORPORATED; HOSPIRA, INCORPORATED; SANDOZ, INCORPORATED; SANOFI-AVENTIS, U.S., L.L.C.; SUN PHARMA GLOBAL FZE; SUN PHARMACEUTICAL INDUSTRIES, INCORPORATED, agent of Caraco Pharmaceutical Laboratories, Limited; MCKESSON CORPORATION, doing business as McKesson Packaging; HOSPIRA WORLDWIDE, L.L.C., formerly known as Hospira Worldwide, Incorporated; SANOFI U.S. SERVICES, INCORPORATED, formerly known as Sanofi-Aventis U.S., Incorporated,

Defendants - Appellees

Appeal from the United States District Court for the Eastern District of Louisiana

Before CLEMENT, SOUTHWICK, and HIGGINSON, Circuit Judges. STEPHEN A. HIGGINSON, Circuit Judge: Dorothy Kuykendall alleges that she used defendants’ prescription chemotherapy drug from 2011 to 2012 and now suffers from permanent hair loss. As a plaintiff in this multidistrict litigation (“MDL”), she was required to Case: 19-30640 Document: 00515492836 Page: 2 Date Filed: 07/16/2020

No. 19-30640 serve defendants with a completed fact sheet disclosing details of her personal and medical history soon after filing her short form complaint. When she failed to do so, the district court dismissed her case with prejudice. For the following reasons, we AFFIRM. I. Defendants are manufacturers of Taxotere, a prescription chemotherapy drug commonly prescribed to patients diagnosed with breast cancer, and Docetaxel, the generic version of Taxotere. According to plaintiffs, defendants were aware that their drugs caused hair loss yet failed to warn potential users of this negative side effect. See In re Taxotere (Docetaxel) Prods. Liab. Litig., 220 F. Supp. 3d 1360, 1361 (J.P.M.L. 2016). In 2016, the Judicial Panel on Multidistrict Litigation consolidated all cases with similar claims and transferred them to the Eastern District of Louisiana. Id. As of December 2019, there were 11,971 individual actions pending in this MDL. 1 Soon after the cases were consolidated, the district court issued several pretrial orders intended to streamline the discovery process and ensure the efficient management of plaintiffs’ claims. In Amended Pretrial Order No. 22, the court ordered each plaintiff to complete a Plaintiff Fact Sheet (“PFS”) within seventy-five days of the date that her case was docketed in the MDL. The PFS required each plaintiff to answer detailed questions about her race, family, medical history, cancer diagnosis, and treatment regimen. In addition to the PFS, plaintiffs were required to provide defendants with authorizations for the release of medical records.

1 U.S. Judicial Panel on Multidistrict Litigation, MDL Statistics and Report: Distribution of Pending MDL Dockets by District (Dec. 16, 2019), available at https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDLs_by_District-December-16- 2019.pdf. 2 Case: 19-30640 Document: 00515492836 Page: 3 Date Filed: 07/16/2020

No. 19-30640 If a plaintiff failed to complete and serve the necessary disclosures by the deadline, defendants were directed to file a notice of deficiency on MDL Centrality, an electronic database. After receiving a notice of deficiency, plaintiffs had thirty days to submit a compliant PFS. If they failed to do so, defendants were permitted to serve a notice of non-compliance upon Plaintiffs’ Liaison Counsel. 2 Plaintiffs were then given an additional thirty days to cure the deficiencies. If a plaintiff still failed to provide the “complete and verified disclosures” by that deadline, defendants could add the plaintiff to the court’s “call docket” for the next scheduled hearing. The district court’s pretrial order explicitly warned plaintiffs that their cases could be dismissed if they failed to establish good cause during the hearing for their continued discovery deficiencies. Dorothy Kuykendall filed a short form complaint on November 29, 2018. Accordingly, her PFS was due seventy-five days later, on February 12, 2019. After she failed to file the required form by the deadline, defendants served her with a notice of non-compliance on March 26, 2019. 3 Under Pretrial Order No. 22A, the notice of non-compliance gave Kuykendall an additional thirty days, or until April 25, 2019, to serve defendants with the necessary information. When Kuykendall again failed to cure the deficiencies, the defendants placed her name on the call docket for the next court hearing, scheduled for

2 The court appointed liaison counsel for plaintiffs and defendants. 3 There is no record that defendants served Kuykendall with a notice of deficiency before they served her with the notice of non-compliance. However, at the May 29, 2019 hearing, Kuykendall did not object to the fact that she did not receive a notice of deficiency before the notice of non-compliance, and instead admitted that she had failed to provide any PFS prior to a few days before the hearing. On appeal, she likewise does not object to the fact that she was not provided with an initial notice of deficiency before the hearing. 3 Case: 19-30640 Document: 00515492836 Page: 4 Date Filed: 07/16/2020

No. 19-30640 May 21, 2019. Next to Kuykendall’s name, the defendants included a notation stating “No PFS submitted.” The court was unable to address Kuykendall’s case during the May 21 conference, so it scheduled a follow-up conference for May 29, 2019. On May 21, Kuykendall uploaded a few documents to MDL Centrality, including a signed declaration and two photographs, but she did not file a PFS. Five days later, Kuykendall finally submitted a PFS, though the document was missing responses to several important questions, including spousal information, weight and height information, and information regarding her prescribing doctor. At the May 29 hearing, the defendants acknowledged that Kuykendall had submitted a PFS after the original hearing date but before the rescheduled hearing. However, defense counsel informed the court that Kuykendall’s PFS contained “a significant number of blanks,” including “the date of cancer diagnosis, the cancer markers that go to staging, the dates of chemotherapy treatment, the name of the prescribing oncologist, prior medication history, and a list of other medical providers.” Kuykendall’s counsel acknowledged that her PFS was incomplete, but reported that it was his belief that “[a]ll of the appropriate boxes have been checked.” He further explained that any remaining blanks were caused by the “difficulty” of obtaining information from clients, including “health insurance information [and] identifying each pharmacy drugstore.” The court gave Kuykendall an additional thirty days to cure the deficiencies identified by defendants during the hearing. On July 1, 2019, after the court’s extension had expired and Kuykendall had not provided an updated PFS, the defendants sent Kuykendall a notice of deficiency that identified the continued omissions and deficiencies in her PFS. Two days later, on July 3, defendants included Kuykendall on a list of plaintiffs whose cases were subject 4 Case: 19-30640 Document: 00515492836 Page: 5 Date Filed: 07/16/2020

No. 19-30640 to immediate dismissal. In a short order without analysis, the district court dismissed Kuykendall’s case with prejudice on July 11, 2019. That same day, Kuykendall filed a letter in which she claimed to be “blindsided” by the list of deficiencies alleged by the defendants during the May 29 hearing.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Woodson v. Surgitek, Inc.
57 F.3d 1406 (Fifth Circuit, 1995)
Compaq Computer Corp. v. Ergonome Inc.
387 F.3d 403 (Fifth Circuit, 2004)
Sealed v. Sealed
452 F.3d 415 (Fifth Circuit, 2006)
Link v. Wabash Railroad
370 U.S. 626 (Supreme Court, 1962)
In Re Fannie Mae Securities Litigation
552 F.3d 814 (D.C. Circuit, 2009)
Rose v. Batson v. Neal Spelce Associates, Inc.
765 F.2d 511 (Fifth Circuit, 1985)
Michael Henry Ferdik v. Joe Bonzelet, Sheriff
963 F.2d 1258 (Ninth Circuit, 1992)
Gemeral Earnest Berry, Jr. v. Cigna/rsi-Cigna
975 F.2d 1188 (Fifth Circuit, 1992)
Federal Deposit Insurance Corporation v. Conner
20 F.3d 1376 (Fifth Circuit, 1994)
Julie Demahy v. Wyeth, Incorporated
702 F.3d 177 (Fifth Circuit, 2012)
Brandon Thrasher v. Amarillo Police Dept
709 F.3d 509 (Fifth Circuit, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
In re: Taxotere Prod Liability, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-taxotere-prod-liability-ca5-2020.